A2A-O-02

N/A

Report date: 2023/12/06 15:51:40
NME

Base Information

Drug NameA2A-O-02
Drug Alias NameProtein-protein interaction inhibitor (A2A Pharmaceuticals)Yap-Tead inhibitors (A2A Pharmaceuticals)A2A_O-02A2A-O-02A2A-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionYAP and TEAD interaction inhibitor
TargetsTranscriptional coactivator YAP1Transcriptional enhancer factor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesA2A Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesA2A Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A